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Case Report
The patient, an unmarried woman of 22 years, presented with a history of irregular periods for four years. From the age of 19 she had developed scanty fine facial hairs, gained weight, and noticed a pronounced increase in her muscular power.
Examination showed minimal hirsutism. The blood pressure was 140/80 mm Hg. There were no abdominal striae or palpable masses. Vaginal examination showed nothing abnormal and there was no clitoral hypertrophy. The haemoglobin was 18-0 g/100 ml and the P.C.V. 57°,'. The red cell mass was 32 ml/kg and the whole blood volume 61 ml/kg, indicating a moderate polycythaemia. Serum electrolytes and glucose tolerance were normal. Serum cholesterol was persistently low, 90-110 mg/100 ml. Intravenous pyelography showed the left kidney to be displaced downwards and a soft tissue shadow was visible over the upper pole.
The 17-oxogenic steroid (17-OGS) and outputs are shown in Table I . The 17-OS output was 10 times the normal value. Fractionated 17-OS steroids (Table II) showed that the major androgen appearing in the urine was dehydroepiandrosterone. The raised 11 oxy-17 oxosteroids suggested an adrenal origin. There was no suppression of 17-OS and 17-OGS with dexamethasone (Table III) .
The I.V.P. and endocrne investigations indicated the presence The postoperative recovery was uncomplicated. Four days after operation she had a normal period and has since menstruated regularly at monthly intervals. The muscular hypertrophy and hirsutism regressed. Within two weeks of the removal of the tumour the endocrine profile was normal. (Table IV.) (Lipsett and Wilson, 1962; Mills, 1964) . Furthermore, despite the high levels of urinary C19 steroids there were minimal signs of masculinization. Harrison et al. (1966) suggested that in a case of adrenal cortical carcinoma where the excretion of dehydroepiandrosterone was 21-25 mg/24 hr virilization may have been prevented by a high production of oestrogens. In this case the total excretion of 17-OS was 10 times greater than in their case and the oestrogen excretion was low, indicating that a more likely explanation for the lack of viriliation was the low androgenic potency of dehydroepiandrosterone and aetiocholanolone. The relative potency of androgenic steroids is difficult to assess in man, but animal experiments by Dorfhan and Shipley (1956) and Aberhalden (1953) indicated that dehydroepiandrosterone and aetiocholanolone have negligible androgenic potential, while androsterone has about 10% of the potency of testosterone. Aetiocholanolone and dehydroepiandrosterone in the present case formed over 80% of the C19 steroid excretion.
This patient had a pronounced polycythaemia despite normal or marginally raised 17-OGS excretion. Polycythaemia is often encountered in Cushing's syndrome but is said to be unusual with predominantly androgen-producing tumours. Analysis of the series of Rapaport and his colleagues (1952), however, shows that in the adrenal tumours producing Cushin's synl drome 26%' of cases where the haemoglobin was reported had polycythaemia, and 15% of cases diagnosed as androgenic tumours had a raised haemoglobin.
The low cholesterol levels seen in this patient may be explained by the high androsterone levels. Androsterone when given intramuscularly has been shown to cause a sharp fall of plasma cholesterol (Mills, 1964) , but the mechanism by which this occurs is unknown. The amenorrhoea associated with adrenal tumours is due to suppression of FSH, but it is interesting to note that the LH levels were exceedingly high.
Transient Dysaesthesiae and Persistent Leucocytosis after Clioquinol Therapy S. I. TERRY British Medical J7ournal, 1971, 3, 745 The following case of transient dysaesthesiae and persistent neutrophil leucocytosis after self-medication with halogenated oxyquinolines for diarrhoea, secondary to giardiasis, is of interest. Since November 1970 he has been attending the Hospital for Tropical Diseases, London, where clinical examination showed a well-nourished man, normotensive, with no abnormal physical findings. However, stool microscopy showed cysts of Giardia intestinalis and ova of Ascaris lumbricoides, and the mean white blood cell total was 14,950/mm3 (neutrophils 70%, lymphocytes 22%, monocytes 40/0, eosinophils 4%). The leucocytosis persisted for six months. The E.S.R. was 13 mm/l hr, haemoglobin 15-9 g/ 100 ml, and the film appeared normal. Three-day faecal fat excretion was 24 g, or 8 g/24 hr. Five-hour urine D-xylose (25 g D-xylose orally) was 5 g. The following investigations were done in an attempt to find a pyogenic cause for the neutrophil leucocytosis: midstream specimen of urine microscopy and culture, stool culture, throat swab culture, and chest x-ray examination, but these were all normal. There was no evidence of other parasitic infections.
Since returning to this country the patient has been asymptomatic and his giardiasis and ascariasis have been effectively treated.
Giardiasis is a well-known cause of diarrhoea and minor degrees of malabsorption and this seems to be the cause of the patient's gastrointestinal symptoms.
Comment
It has been suggested that halogenated oxyquinolines are useful in the treatment and prophylaxis of travellers' diarrhoea, though the evidence to support this is insubstantial (Richards, 1970 (Richards, , 1971 Marsden and Knight, 1971) . Also, these drugs are freely available to the general public without prescription as they have been assumed to have no serious side effects. Recent reports from Japan suggest that this is not so, and neurological lesions have been described (Fullerton and O'Sullivan, 1968; Sobue et al., 1971; Tsubati et al., 1971) . These usually take the form of a mixed peripheral neuropathy, the striking features of which are, in order of frequency, dysaesthesiae, ataxia of gait, and muscle weakness, but optic nerve damage has also been described. It has also been reported that the onset of neurological symptoms is associated with systemic disturbance, increased white blood cell total in the peripheral blood, and a raised erythrocyte sedimentation rate (Fullerton and O'Sullivan, 1968) .
The persistent neutrophil leucocytosis and transient painful dysaesthesiae in this case are assumed to be secondary to halogenated oxyquinoline therapy as the circumstantial evidence is strong. This is the first case described in the United Kingdom, and though the frequency with which side effects have been reported in Japan may be due to some genetic predisposition (British Medical 7ournal, 1971) , a suggested association between these drugs, the dysaesthesiae, and leucocytosis in this case raises the possibility that greater awareness of the condition will lead to more frequent recognition (Lancet, 1971) .
My thanks are due to Dr. R. Knight for his advice and encouragement and to Professor A. W. Woodruff for allowing me to publish data on a patient under his care.
